Physician profile
Steven Stogner
NPI 1699884288
$437.51
in general payments reported to CMS, 2019-2025
14 companies · $28.82 in 2025
The $28.82 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $29.00 · 2021: $15.23 · 2022: $100 · 2023: $41.68 · 2024: $18.67 · 2025: $28.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $111.58 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Chiesi USA, INC. | $46.62 | 2021-2022 | |
| Octapharma USA, INC. | $41.68 | 2023 | Panzyga |
| Glaxosmithkline, LLC. | $40.79 | 2019 | |
| Becton, Dickinson and Company | $35.69 | 2022 | |
| Stryker Corporation | $28.82 | 2025 | Sage Self Oral Care |
| Abbott Laboratories | $27.69 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $20.78 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $19.47 | 2019 | |
| Advanced Respiratory, INC | $15.05 | 2019 | |
| Genentech USA, INC. | $13.17 | 2019 | |
| Inari Medical, INC. | $12.53 | 2022 | |
| La Jolla Pharmaceutical Company | $12.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Stogner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.